Imaging Mass Cytometry in Immuno-Oncology

Tiziana Cotechini1, Oliver Jones2, Charles Colin Thomas Hindmarch3

  • 1Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada. t.cotechini@queensu.ca.

Insights

Imaging mass cytometry (IMC) allows simultaneous detection of up to 50 markers in fixed tissues. This multiplex imaging technique provides spatially resolved insights into the tumor-immune microenvironment (TiME) for research.

Area of Science:

  • Biomedical research
  • Immunology
  • Oncology

Background:

  • Accurate profiling of the tumor-immune microenvironment (TiME) is crucial for understanding cancer biology and developing effective therapies.
  • Simultaneous detection of multiple proteins within the TiME is essential for comprehensive analysis.

Purpose of the Study:

  • To provide an overview of the imaging mass cytometry (IMC) workflow for in situ profiling of the TiME.
  • To highlight the potential of IMC in pre-clinical and clinical research.

Main Methods:

  • Overview of the IMC workflow, including sample fixation, multiplex panel design, tissue staining, and data analysis.
  • Utilizing the Hyperion™ imaging system for multiplex imaging.

Main Results:

  • IMC enables detection of up to 50 markers at subcellular resolution on fixed tissues.
  • Provides spatially resolved information critical for understanding the TiME.

Conclusions:

  • IMC is a powerful multiplex imaging modality for detailed analysis of the TiME.
  • The presented workflow facilitates the application of IMC in both pre-clinical and clinical settings.

Related Concept Videos